Ferdinand Leya

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Designing materials for biology and medicine

Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I)

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

Selection of Surgical or Percutaneous Coronary Intervention Provides Differential Longevity Benefit

Fourth Universal Definition of Myocardial Infarction (2018)

Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease

Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Thrombolytic Therapy with Use of Alteplase (rt-PA) in Peripheral Arterial Occlusive Disease: Review of the Clinical Literature

Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Prospects for Cardiovascular Research

Comparison of results of intracoronary implantation of the Palmaz-Schatz stent with conventional balloon angioplasty in chronic total coronary arterial occlusion

The current status and future direction of percutaneous coronary intervention without on‐site surgical backup: An expert consensus document from the Society for Cardiovascular Angiography and Interventions

The Protective Effects of Estrogen on the Cardiovascular System

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure

Retrieval and analysis of particulate debris after saphenous vein graft intervention

A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial

Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT)

Treatment and Prevention of Heparin-Induced Thrombocytopenia

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury

Intra-arterial Prourokinase for Acute Ischemic Stroke

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Cardiac troponin levels in pregnant women with severe pre-eclampsia

Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials

Coronary laser angioplasty

Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina

Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential

Cost Identification of Abdominal Aortic Aneurysm Imaging by Using Time and Motion Analyses

Management and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention

Diabetes and Atherosclerosis

Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction

Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Natriuretic Peptides

Three-year follow-up of the argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI)

Which thrombolytic agent should one choose?

Heparin-induced thrombocytopenia and cardiac surgery

Guidelines for Percutaneous Coronary Interventions

Treatment and Prevention of Heparin-Induced Thrombocytopenia

Task Force on Sudden Cardiac Death of the European Society of Cardiology

Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes

Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Heparin-induced thrombocytopenia and cardiac surgery

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

Percutaneous Transluminal Coronary Angioplasty

A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

Immunosuppressive Drugs for Kidney Transplantation

EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection

Biomarkers in Heart Failure

Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases

Advances in Coronary Angioplasty

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Outcome of Reoperative Coronary Bypass Surgery Versus Coronary Angioplasty After Previous Bypass Surgery

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Abciximab Facilitates the Rate and Extent of Thrombolysis

Air Pollution and Cardiovascular Disease

Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic Lesions

Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Hirudin in Acute Myocardial Infarction

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

Angioplasty after Intra-Arterial Thrombolysis for Acute Occlusion of Intracranial Arteries

Our Preoccupation With Coronary Luminology

Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention

Critical Analysis of Coronary Artery Bypass Graft Surgery: A 30-Year Journey

A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization

Aortocoronary Saphenous Vein Graft Disease

Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT)

Thermal Preconditioning Before Rat Arterial Balloon Injury

Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection

Predictors and Sequelae of Distal Embolization During Saphenous Vein Graft Intervention From the CAVEAT-II Trial

Previous Angina Alters In-Hospital Outcome in TIMI 4

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Coronary Plaque Disruption

Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

One-Year Follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I)

TIMI Frame Count

Mechanisms of Pulsed Laser Ablation of Biological Tissues

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor

Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center

In-Hospital Cost of Percutaneous Coronary Revascularization

A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia

Troponin I Levels in Patients with Preeclampsia

Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial

The Efficacy of Brain Natriuretic Peptide Levels in Differentiating Constrictive Pericarditis From Restrictive Cardiomyopathy

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial

A Multicenter, Randomized Trial of Coronary Angioplasty Versus Directional Atherectomy for Patients With Saphenous Vein Bypass Graft Lesions

Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era.

Percutaneous transluminal coronary angioplasty for unstable angina: Predictors of outcome in a multicenter study

Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.

Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.

The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis.

Length of Hospital Stay and Complications After Percutaneous Transluminal Coronary Angioplasty

The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. Heparin Registry Investigators.